MA45274A - Préparations améliorées de cellules progénitrices hépatiques adultes - Google Patents

Préparations améliorées de cellules progénitrices hépatiques adultes

Info

Publication number
MA45274A
MA45274A MA045274A MA45274A MA45274A MA 45274 A MA45274 A MA 45274A MA 045274 A MA045274 A MA 045274A MA 45274 A MA45274 A MA 45274A MA 45274 A MA45274 A MA 45274A
Authority
MA
Morocco
Prior art keywords
progenitor cell
cell preparations
hepatic progenitor
adult hepatic
improved adult
Prior art date
Application number
MA045274A
Other languages
English (en)
Inventor
Pierre-Edouard Dollet
Catherine Lombard
Mustapha Najimi
Etienne Sokal
Original Assignee
Univ Catholique Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of MA45274A publication Critical patent/MA45274A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/407Liver; Hepatocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/067Hepatocytes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067Liver cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/14Coculture with; Conditioned medium produced by hepatocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00Microcarriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Developmental Biology & Embryology (AREA)
MA045274A 2016-03-02 Préparations améliorées de cellules progénitrices hépatiques adultes MA45274A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16158327 2016-03-02

Publications (1)

Publication Number Publication Date
MA45274A true MA45274A (fr) 2019-01-09

Family

ID=55696855

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045274A MA45274A (fr) 2016-03-02 Préparations améliorées de cellules progénitrices hépatiques adultes

Country Status (14)

Country Link
US (1) US20190046584A1 (fr)
EP (1) EP3423566A1 (fr)
JP (1) JP2019506890A (fr)
KR (1) KR20180114073A (fr)
CN (1) CN108779440A (fr)
AU (1) AU2017225825A1 (fr)
BR (1) BR112018067597A8 (fr)
CA (1) CA3013427A1 (fr)
EA (1) EA039743B1 (fr)
IL (1) IL261383A (fr)
MA (1) MA45274A (fr)
MX (1) MX2018010508A (fr)
SG (1) SG11201807041PA (fr)
WO (1) WO2017149059A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3016665T3 (da) 2013-07-05 2019-11-25 Univ Catholique Louvain Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser
TW202035682A (zh) 2018-12-14 2020-10-01 比利時商普羅米修亞生物科技股份有限公司 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途
SG11202106169SA (en) 2018-12-14 2021-07-29 Promethera Therapeutics Sa Cell composition comprising liver progenitor cells expressing hla-e
KR20220004977A (ko) 2019-03-26 2022-01-12 프로메테라 테라푸틱스 에스에이 만성 간부전의 급성 악화를 치료하기 위한 성체 간 전구 세포
US20220202874A1 (en) 2019-03-26 2022-06-30 Promethera Therapeutics Sa Adult Liver Progenitor Cells for Treating Non-Alcoholic Fatty Liver Disease
WO2020221842A1 (fr) 2019-04-30 2020-11-05 Promethera Biosciences S.A./N.V. Préparation de cellules progénitrices allogéniques humaines dérivées du foie
US20220213442A1 (en) 2019-04-30 2022-07-07 Promethera Therapeutics Sa Preparation of human allogeneic liver-derived progenitor cells
IL291886A (en) 2019-10-09 2022-06-01 Cellaion Sa Use of progenitor cells or liver stem cells, their lysates, and/or conditioned growth medium - in disorders characterized by hyperpermeability of the blood vessels
EP3881853A1 (fr) 2020-03-20 2021-09-22 Promethera Therapeutics Sa Cellules progénitrices allogéniques humaines dérivées du foie à utiliser dans le traitement des maladies pulmonaires inflammatoires et infectieuses et de l'inflammation systémique
CN111778268B (zh) * 2020-06-03 2022-06-21 武汉仝干医疗科技股份有限公司 增强解毒功能基因片段及改造的HepG2细胞
WO2023180122A1 (fr) 2022-03-24 2023-09-28 Université Catholique de Louvain Utilisation de cellules progénitrices allogéniques humaines dérivées du foie pour traiter et/ou prévenir la sénescence cellulaire
WO2024200809A1 (fr) 2023-03-31 2024-10-03 Université Catholique de Louvain Utilisation de cellules progénitrices allogéniques humaines dérivées du foie pour traiter et/ou prévenir le carcinome hépatocellulaire

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126219A1 (fr) * 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Cellules progeniteurs hepatiques
ES2359874T5 (es) * 2005-12-21 2014-12-12 Universite Catholique De Louvain Células madre hepáticas aisladas
DK2281875T3 (en) * 2005-12-21 2018-06-06 Univ Catholique Louvain Isolated liver stem cells
WO2009139419A1 (fr) * 2008-05-14 2009-11-19 公立大学法人横浜市立大学 Cellule souche hépatique humaine, son procédé de préparation, procédé d’induction de sa différenciation et son procédé d’utilisation
US8415149B2 (en) * 2010-05-06 2013-04-09 Gwo Xi Stem Cell Applied Technology Co., Ltd. Hepatic progenitor cells and uses thereof
US9775890B2 (en) * 2012-01-25 2017-10-03 Université Catholique de Louvain Factor Xa inhibitor used with liver-derived progenitor cells
DK3016665T3 (da) * 2013-07-05 2019-11-25 Univ Catholique Louvain Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser
CN105658786B (zh) * 2013-08-28 2020-07-03 普罗米迪拉生物科学公司 用于生产成人肝脏祖细胞的方法

Also Published As

Publication number Publication date
SG11201807041PA (en) 2018-09-27
EP3423566A1 (fr) 2019-01-09
AU2017225825A1 (en) 2018-08-16
EA039743B1 (ru) 2022-03-05
EA201891913A1 (ru) 2019-02-28
US20190046584A1 (en) 2019-02-14
MX2018010508A (es) 2018-11-09
BR112018067597A8 (pt) 2019-10-15
KR20180114073A (ko) 2018-10-17
CA3013427A1 (fr) 2017-09-08
IL261383A (en) 2018-10-31
CN108779440A (zh) 2018-11-09
JP2019506890A (ja) 2019-03-14
BR112018067597A2 (pt) 2019-01-08
WO2017149059A1 (fr) 2017-09-08

Similar Documents

Publication Publication Date Title
IL261383A (en) Improved preparations of adult human liver stem cells
DK3440102T3 (da) T-cellereceptorer
DK3303568T3 (da) Celle
DK3448882T3 (da) Anti-kk-lc-1-t-cellereceptorer
DK3132034T3 (da) Terapeutikum
DK3113883T3 (da) Cellesorteringssystem der anvender mikrofremstillede komponenter
DK3142763T3 (da) Legetøjskonstruktionssystem med funktionskonstruktionselementer
IL249298A0 (en) Immuno-modulatory progenitor (imp) cells
DK3223829T3 (da) Behandling af sygdomme associeret med hepatisk stellat-celleaktivering under anvendelse af ammoniak-sænkende terapier
DK3039123T3 (da) Fremgangsmåde til at fremstille voksne leverprogenitorceller
DK3489290T3 (da) Kompositmembran
DK3427323T3 (da) Brændselscelle
DK3766582T3 (da) Cellekultur
DK3094322T3 (da) Administration af tasimelteon i fastende tilstand
DK3177388T3 (da) Membran
FR3023067B1 (fr) Cellules tandem multifils
DK3288640T3 (da) Tørshampoosammensætning
ES2914082T8 (es) Procedimiento de generación de progenitores de células T
MA45498A (fr) Cellules treg génétiquement modifiées
ES1103231Y (es) Conjunto de asientos infantiles
ES2980857T3 (es) Celda fotovoltaica de unión en tándem
FR3021480B1 (fr) Commutateur de trames numeriques
FR3050173B1 (fr) Toile anti-naufrage
DK3326707T3 (da) Ringformet tætning i et stykke
FR3039139B3 (fr) Emballage-blister pour pile-bouton